Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?
GRFS, Therapy
18 Sep 2023

Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?

This pilot study reported the effects of Galileo Therapy on fall risk and muscle power in MS (multiple sclerosis) patients (20Hz, pos. 1.5, slightly flexed legs (20°), 5*1 min., 3/week, 8 weeks). Just 5 minutes Galileo Therapy 3 times per week showed decreased fall-risk and significantly improved balance (+12%), muscle function and muscle Power (+12%) as well as knee torque at flexor (+12) and extensor (15%)…

Continue reading
Galileo Research Facts No. 94: Can Galileo Therapy improve the disability status of MS patients?
GRFS, Therapy
17 Sep 2023

Galileo Research Facts No. 94: Can Galileo Therapy improve the disability status of MS patients?

This study investigated the effects of 8 weeks of Galileo Therapy on different disease related scores (PDDS, MSCF) in MS (Multiple Sclerosis) patients (20Hz, pos. 1.5, 5*1 min., 3/week, 8 weeks, 20° bent legs). The results show not only improvements in PDDS and PSAT-3 by up to 18% but also an increase in HSFC (MS Functional Composite: walking distance, hand function, calculation test) in average by 0.36SD…

Continue reading
Galileo Research Facts No. 82: Can Galileo Therapy improve muscle function and cognition in MS patients?
GRFS, Therapy
16 Sep 2023

Galileo Research Facts No. 82: Can Galileo Therapy improve muscle function and cognition in MS patients?

This study investigated the effects of 8 weeks of Galileo Therapy on the disability status of MS (Multiple Sclerosis) patients (20Hz, pos. 1.5, 5*1 min., 3/week, 8 weeks, 20° bent legs). The results show significant improvements in muscle function, cognition and disability status: +0,4 points motor function & cognition, +8% hand motor function, +14% disability status, +19% calculating & memory +26% gait speed…

Continue reading